| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2774519 | Endocrinología y Nutrición | 2007 | 18 Pages |
Abstract
Currently available data on the effectiveness of prebiotics, short-chain fatty acids, probiotics, fish oils (omega-3-fatty acids), antioxidants, and transforming growth factor (TGF-β) are too limited to allow the use of these substances to be recommended as primary therapy to control inflammation in patients with IBD. Reducing microparticle intake could play a role in controlling active CD.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Juan José Arrizabalaga,